SUMMARY In a survey of 283 deliveries in Swaziland, active syphilis (positive results in the Treponema pallidum haemagglutination assay (TPHA) and the rapid plasma reagin (RPR) test) was found in 37 (13.1 %) and possibly active infection (positive TPHA but negative RPR test results) in a further 87 (30 7%). The perinatal mortality of untreated mothers with active disease was 21-9% (7/32). The RPR test carried out antenatally by nurses had a sensitivity of 36% (13/36) and predictive accuracy of 48% (13/27).
Syphilis is common in several African countries, with a prevalence of around 10% (Widi-Wirski R and D'Costa J, 13th conference technique, OCEAC, Yaounde, Cameroun, 1980).'-`Morbidity seems to be low in adults,'3 but neonatal syphilis is common and there is high perinatal mortality. '3 In 1979 syphilis was shown to be venereal in origin in Swaziland,6 and 6 5% to 14% ofwomen ofchildbearing age had active infection.' The present study assesses the effectiveness of antenatal screening and the perinatal mortality resulting from untreated maternal disease.
Patients and methods
Syphilis screening was provided by nurses for antenatal mothers booking at the Public Health Unit, Mbabane, Swaziland. The rapid plasma reagin (RPR) test (Syfacard-R, Wellcome) using undiluted serum gives a simple positive or negative result. Women with positive results were treated with benzathine penicillin 2-4 MIU a week for three weeks.
During July and November 1986 the syphilis status of mothers was checked at more or less consecutive deliveries at Mbabane Hospital Maternity Unit, and details of screening, treatment, and outcome were Address for reprints: Dr L F Guinness, No 1 Cherchefelle, Chart Lane, Reigate, Surrey RH2 7RN Accepted for publication 20 February 1988 recorded. Serum was obtained and frozen from 100 cord samples and 178 maternal samples. There were five sets of twins, which were each considered as two separate deliveries. The July samples were checked by the RPR test and the Treponema pailidum haemaglutination assay (TPHA) (Syfatect, Wellcome), both in dilution, by the Institute of Tropical Medicine, Antwerp, and the results were confirmed by the fluorescent treponemal antibody absorption (FTA-ABS) test. The November samples were tested by the authors by the RPR test in dilution and by qualitative TPHA only.
Positve RPR test results are evidence of active disease, and become negative after treatment. False positive results at low titres, however, may occur in pregnancy,9 so a titre of 1/1 can only be considered borderline or indicative ofpossibly active syphilis. The TPHA is specific for treponematoses, but titres drop very little after treatment.'0 Thus active syphilis is defined by a RPR titre of 1/2 or more and a positive TPHA result, and possibly active syphilis by a RPR titre of 1/1 or a negative result and a positive TPHA result. 6 Perinatal syphilis serology testing was not available routinely, so all newborns were treated with benzathine penicillin 0-15 MIU, which has appreciably reduced the admission to hospital ofolder infants with congenital syphilis in Mbabane (McGrath E, et al, unpublished observation). 294 Untreated active syphilis was a risk factor in 24 deliveries that resulted in seven perinatal losses, a mortality of29-2%. Mortality in women with possibly active syphilis was 4-6% (4/87) and in those with negative results 2-8% (4/145). The association between perinatal mortality and active syphilis was appreciable, but less than that found by Meheus and avoided. Thus the screen averted 35% (13/37) of losses but missed the remaining 65% (24/37).
Discussion
This survey shows evidence of past or present syphilis in 44% (124/283) of Swazi mothers and active disease in 13% (37/283). This was a very high level of infection, and screening was not very effective in dealing with it. Of mothers with active disease, 65% were missed and few sexual partners were treated, so that an expected perinatal mortality due to syphilis of 3-5% was only reduced to 2-3%.
Despite this poor showing, screening indicated roughly the level of disease and stimulated clinical awareness. Earlier surveys led to screening,"5 but the extent of perinatal and paediatric problems has only been shown recently (McGrath E, et al, unpublished observation). This led to other measures being adopted to combat the problem, including checking for vulval sores in the antenatal clinic, mothers with previous perinatal losses or vulval lesions starting treatment immediately, and all newborn infants receiving benzathine penicillin.
The screening programme for syphilis described could certainly be improved. Mothers should be screened when they book at the antenatal clinic and also in the third trimester3; technically trained staff should check positive results in dilution and with the TPHA. A further problem of screening, however, was the failure to contact women with positive results. Nearly all mothers had antenatal cards, but many cards had no record of the RPR results.
In hospitals that do not provide syphilis screening, a prevalence survey would indicate the extent of the problem and increase clinical awareness. Starting screening, however, will add appreciably to the cost and workload ofantenatal clinics, and few hospitals in Africa can afford comprehensive screening as described above.
In areas with a high level of sexually transmitted disease, mass treatment has been suggested. 13 We think that a one dose prophylactic regimen of penicillin for 
